コンテンツへスキップ
Merck
  • Identification of point mutations in clinical Staphylococcus aureus strains that produce small-colony variants auxotrophic for menadione.

Identification of point mutations in clinical Staphylococcus aureus strains that produce small-colony variants auxotrophic for menadione.

Infection and immunity (2014-01-24)
Melissa A Dean, Randall J Olsen, S Wesley Long, Adriana E Rosato, James M Musser
要旨

Staphylococcus aureus small-colony variants (SCVs) are implicated in chronic and relapsing infections that are difficult to diagnose and treat. Despite many years of study, the underlying molecular mechanisms and virulence effect of the small-colony phenotype remain incompletely understood. We sequenced the genomes of five S. aureus SCV strains recovered from human patients and discovered previously unidentified nonsynonymous point mutations in three genes encoding proteins in the menadione biosynthesis pathway. Analysis of genetic revertants and complementation with wild-type alleles confirmed that these mutations caused the SCV phenotype and decreased virulence for mice.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
メナジオン, crystalline
Sigma-Aldrich
メナジオン重亜硫酸ナトリウム, ≥95% (TLC)
Sigma-Aldrich
メナジオン, meets USP testing specifications
Supelco
Menadione (K3), analytical standard
Sigma-Aldrich
メナジオン重亜硫酸ナトリウム, BioReagent, suitable for cell culture, ≥95% (TLC)
USP
メナジオン, United States Pharmacopeia (USP) Reference Standard
Supelco
メナジオン, Pharmaceutical Secondary Standard; Certified Reference Material
メナジオン, European Pharmacopoeia (EP) Reference Standard